FDA clears Bolton's stent graft system for TAAs

The FDA has approved Bolton Medical's Relay thoracic stent graft with Plus delivery system to use as a minimally invasive treatment for thoracic aortic aneurysms (TAAs) and penetrating atherosclerotic ulcers.

The Relay system offers performance zones to provide varying levels of radial support and apposition; a four-step dual sheath delivery system; various sizes with lengths of 100 to 250 mm and diameters of 22 to 46 mm; and straight and tapered.

Bolton stent grafts have been available in Europe and other international markets since 2005. The U.S. pivotal study included 120 endovascular patients at 30 hospitals across the U.S.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup